Scleroderma, Systemic: Clinical Trials

1 trial for Scleroderma, Systemic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 enrolling by invitation. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Enrolling by invitation 1

Follow Scleroderma, Systemic: new trials by email Literature Review of Scleroderma, Systemic trials Research Report on Scleroderma, Systemic

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases
Shingrix, vaccination with 2 doses of Shingrix vaccine - Systemic Vasculitis, Spondylarthropathies
Phase 4Enrolling by invitationRegion Skane2402024-12-172025-01-10

Narrower conditions

Arthritis (1)  ·  Arthritis, Juvenile (1)  ·  Arthritis, Psoriatic (1)  ·  Giant Cell Arteritis (1)  ·  Herpes Zoster (1)  ·  Polymyalgia Rheumatica (1)  ·  Scleroderma, Diffuse (1)  ·  Spondylarthropathies (1)  ·  Systemic Vasculitis (1)

Broader conditions

Arteritis (1)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Bone Diseases (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Connective Tissue Diseases (1)  ·  DNA Virus Infections (1)  ·  Herpesviridae Infections (1)  ·  Immune System Diseases (1)  ·  Infections (1)  ·  Joint Diseases (1)  ·  Muscular Diseases (1)

Interventions

Vaccination (1)

Sponsors

Region Skane (1)

Countries

Sweden (1)

NIH funding

2023 (1)